Mosaic ImmunoEngineering, Inc. (CPMV)
OTCMKTS · Delayed Price · Currency is USD
0.6231
+0.1997 (47.17%)
Sep 16, 2025, 12:58 PM EDT
Mosaic ImmunoEngineering Market Cap
Mosaic ImmunoEngineering has a market cap or net worth of $4.51 million as of September 16, 2025. Its market cap has decreased by -40.37% in one year.
Market Cap
4.51M
Enterprise Value
6.09M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.62
Market Cap Chart
Since October 15, 2020, Mosaic ImmunoEngineering's market cap has increased from 1.69M to 4.51M, an increase of 167.68%. That is a compound annual growth rate of 22.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 3.07M | -39.62% |
| Dec 31, 2024 | 5.08M | 16.87% |
| Dec 29, 2023 | 4.35M | -39.39% |
| Dec 30, 2022 | 7.17M | -2.75% |
| Dec 31, 2021 | 7.37M | 181.52% |
| Dec 31, 2020 | 2.62M | 55.34% |
| Oct 15, 2020 | 1.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 782.91M |
| Elite Pharmaceuticals | 735.19M |
| Glass House Brands | 548.40M |
| Northwest Biotherapeutics | 379.14M |
| American Oncology Network | 353.52M |
| CytoDyn | 351.92M |